Bio

Academic Appointments


Research & Scholarship

Current Research and Scholarly Interests


Endocrinology, development, hormone, precocious puberty, diabetes, aging, growth disorders, growth hormone, insulin-like growth factors.

Publications

Journal Articles


  • BONE-MINERAL DENSITY DURING TREATMENT OF CENTRAL PRECOCIOUS PUBERTY JOURNAL OF PEDIATRICS Neely, E. K., Bachrach, L. K., Hintz, R. L., Habiby, R. L., Slemenda, C. W., FEEZLE, L., Pescovitz, O. H. 1995; 127 (5): 819-822

    Abstract

    Treatment of adults with gonadotropin releasing hormone analogs has resulted in rapid loss in bone mineral density (BMD). We measured lumbar and femoral neck BMD by dual-energy x-ray absorptiometry during 2 years of depot leuprolide therapy in 13 girls (mean age, 7.5 years; mean bone age, 10.9 years). At baseline, BMD was elevated for age and concordant with the advanced skeletal age. During therapy with gonadotropin releasing hormone analog, BMD values increased and BMD standard deviation scores for age and skeletal age did not change.

    View details for Web of Science ID A1995TD93100031

    View details for PubMedID 7472845

  • NON-ISLET-CELL TUMOR-ASSOCIATED WITH HYPOGLYCEMIA IN A CHILD - SUCCESSFUL LONG-TERM THERAPY WITH GROWTH-HORMONE JOURNAL OF PEDIATRICS Agus, M. S., Katz, L. E., SATINSMITH, M., Meadows, A. T., Hintz, R. L., Cohen, P. 1995; 127 (3): 403-407

    Abstract

    Hypoglycemia occurred in a 2-year-old girl with neuroblastoma. Initially, growth hormone secretion was suppressed, and she had low levels of insulin-like growth factor (IGF)-I and IGF binding protein-3, but elevated levels of large molecular weight IGF-II. We postulated that the pathogenesis of her hypoglycemia involved production of IGF-II by her neuroblastoma, leading to GH suppression and an abnormally elevated ratio of IGF to IGF binding protein. She was successfully treated with growth hormone; treatment was associated with normalization of the growth hormone-dependent growth factor levels and with euglycemia.

    View details for Web of Science ID A1995RT73800011

    View details for PubMedID 7658270

  • NORMAL RANGES FOR IMMUNOCHEMILUMINOMETRIC GONADOTROPIN ASSAYS JOURNAL OF PEDIATRICS Neely, E. K., Hintz, R. L., Wilson, D. M., Lee, P. A., Gautier, T., Argente, J., Stene, M. 1995; 127 (1): 40-46

    Abstract

    We sought to establish normative data for spontaneous and gonadotropin-releasing hormone (GnRH)-stimulated serum luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels measured by new immunochemiluminometric assays (ICMA) in children and adolescents.Random serum samples were obtained from 375 normal subjects (0.1 to 17.7 years, 230 female subjects). Intravenous GnRH stimulation tests were performed in 41 normal subjects (4.8 to 18 years, 20 female subjects). Normal ranges were calculated by age and Tanner stage. Immunochemiluminometric assays of LH and FSH concentrations were compared with levels obtained by a sensitive immunofluorometric assay and a less sensitive radioimmunoassay.Random gonadotropin concentrations in normal children followed the pattern of transient elevation in infancy, low but measurable prepubertal levels, and markedly increased values at puberty. Spontaneous LH levels were higher in male infants but were not statistically different in boys and girls after infancy. Mean prepubertal LH was 0.04 +/- 0.04 IU/L (n = 66), rising 100-fold during puberty. Spontaneous FSH levels were much higher than LH values, were higher in female infants, and rose threefold at puberty. Peak GnRH-stimulated LH was identical in prepubertal boys and girls (1.8 +/- 1.3 IU/L, n = 17) and increased 20-fold at puberty. Mean peak GnRH-stimulated FSH was highest in prepubertal female subjects. Luteinizing hormone values measured by ICMA and immunofluorometric assay were highly correlated, but radioimmunoassay levels diverged markedly from ICMA levels at lower concentrations. Because absolute levels were higher, FSH values correlated adequately in the three assays throughout the normal physiologic range.Measurement of LH by ICMA is much more sensitive than older assay methods. Spontaneous LH can be accurately measured by ICMA to the very low levels present in normal prepubertal children, providing a potentially important biochemical discriminator of pubertal status. An ICMA GnRH-stimulated LH level greater than 5 IU/L is suggestive of maturing gonadotropin secretion. The ICMA LH assays provide significant enhancement in sensitivity; these assays should be used when levels may be low, and by their accuracy may reduce the time and expense of testing procedures.

    View details for Web of Science ID A1995RH63700006

    View details for PubMedID 7608809

  • INVESTIGATION INTO THE POTENTIAL PHYSIOLOGICAL SOURCES OF RAT MILK IGF-I AND IGF-BINDING PROTEINS JOURNAL OF ENDOCRINOLOGY Donovan, S. M., Hintz, R. L., Rosenfeld, R. G. 1995; 145 (3): 569-578

    Abstract

    We have previously reported the presence of IGF-I and IGF-binding proteins (IGFBP-2, -3 and -4) in rat milk. Herein, the potential sources of rat milk IGF-I and IGFBPs were investigated. Lactating dams (day 14 postpartum) were separated from their pups and injected intraperitoneally with 0.45 microCi 125I-IGF-I or 125I-IGFBP-3. After 3 h, serum and milk of rats receiving 125I-IGF-I contained 7642 +/- 3121 and 14,455 +/- 7837 c.p.m./ml respectively. Serum and milk of rats given 125I-IGFBP-3 contained 7232 +/- 1366 and 10,371 +/- 4091 c.p.m./ml respectively. Sephacryl S-200 gel filtration chromatography demonstrated that the 125I-IGF-I in both serum and milk was primarily in the 150 kDa IGF-binding complex, whereas the distribution of 125I-IGFBP-3 differed between serum and milk. In serum, most of the 125I-IGFBP-3 was in the 150 kDa fraction, while most 125I-IGFBP-3 in milk was in the 40 kDa fraction. Northern analysis of liver showed IGFBP-1 and -3 mRNA expression, with variable expression of IGFBP-2 and -4 mRNA. In contrast, mammary tissue expressed only IGFBP-2 and -4 mRNA, suggesting that these IGFBPs in milk may arise from de novo synthesis within the mammary gland. The lack of detectable IGFBP-3 mRNA in mammary tissue and the translocation of 125I-IGFBP-3 from the serum suggest that milk IGFBP-3 arises from the maternal circulation.

    View details for Web of Science ID A1995RB15700020

    View details for PubMedID 7543555

  • DIAGNOSTIC CONTROVERSY - THE DIAGNOSIS OF CHILDHOOD GROWTH-HORMONE DEFICIENCY REVISITED JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM Rosenfeld, R. G., ALBERTSSONWIKLAND, K., Cassorla, F., FRASIER, S. D., Hasegawa, Y., Hintz, R. L., LaFranchi, S., Lippe, B., Loriaux, L., Melmed, S., Preece, M. A., Ranke, M. B., Reiter, E. O., Rogol, A. D., Underwood, L. E., Werther, G. A. 1995; 80 (5): 1532-1540

    View details for Web of Science ID A1995QW61100015

    View details for PubMedID 7538145

  • GROWTH-HORMONE STIMULATES INSULIN-LIKE GROWTH FACTOR-I ACTIONS ON ADULT ARTICULAR CHONDROCYTES JOURNAL OF ORTHOPAEDIC RESEARCH Smith, R. L., PALATHUMPAT, M. V., Ku, C. W., Hintz, R. L. 1989; 7 (2): 198-207

    Abstract

    We report effects of adding insulin-like growth factor I (IGF-I) and methionyl human growth hormone (GH), alone or in combination, to adult bovine articular chondrocytes plated at high density. Purified human and synthetic IGF-I stimulated chondrocyte DNA and proteoglycan synthesis. GH had no effect on either process. However, GH added in combination with IGF-I increased proteoglycan, cell-associated proteoglycan, and keratan sulfate synthesis over levels observed with IGF-I alone. IGF-I and GH did not alter the hydrodynamic size of proteoglycans or synthesis of collagen. Our results show that GH and IGF-I act together to stimulate adult chondrocyte extracellular matrix synthesis.

    View details for Web of Science ID A1989T300200006

    View details for PubMedID 2918420

Stanford Medicine Resources: